Sign inGet started

Pavco Pamela

Insider CIK 1426651 · RXII Chief Development Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
RXII RXi Pharmaceuticals Corp A Award deriv2017-02-012017-02-037,000— $07,000SEC↗
RXII RXi Pharmaceuticals Corp A Award deriv2016-12-162016-12-2011,111— $011,111SEC↗
RXII RXi Pharmaceuticals Corp A Award2016-12-162016-12-2011,111$0.90 $10.0K17,173SEC↗
RXII RXi Pharmaceuticals Corp A Award deriv2016-02-102016-02-1266,000— $066,000SEC↗
RXII RXi Pharmaceuticals Corp A Award deriv2015-06-022015-06-036,250— $06,250SEC↗
RXII RXi Pharmaceuticals Corp A Award deriv2015-06-022015-06-036,250— $06,250SEC↗
RXII RXi Pharmaceuticals Corp A Award2015-06-022015-06-0312,500$0.40 $5.0K33,718SEC↗
RXII RXi Pharmaceuticals Corp A Award deriv2015-06-012015-06-0266,000— $066,000SEC↗
RXII RXi Pharmaceuticals Corp A Award deriv2014-06-022014-06-0466,000— $066,000SEC↗
RXII RXi Pharmaceuticals Corp A Award deriv2013-06-072013-06-112,000,000— $02,000,000SEC↗